Auteur M. C. PERAULT-POCHAT

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020

E. BOUQUET ; C. EIDEN ; B. FAUCONNEAU ; C. PION ; French Addictovigilance Network ; S. PAIN ; M. C. PERAULT-POCHAT | 2022
Dans Scientific Reports (Vol.12, 2022) Article : Périodique

Cannabis is the main illicit psychoactive substance used by pregnant women in France. The aim of the present national survey was to describe adverse events (AEs) of recreational cannabis use during pregnancy reported to the French Addictovigilan[...]

Plus d'info

Ajouter à la sélection

Lien externe

Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017)

E. BOUQUET ; S. PAIN ; C. EIDEN ; E. JOUANJUS ; N. RICHARD ; B. FAUCONNEAU ; M. C. PERAULT-POCHAT ; French Addictovigilance Network | 2021
Dans British Journal of Clinical Pharmacology (Vol.87, n°10, October 2021) Article : Périodique

Aims: To describe the adverse events (AEs) of recreational cannabis use in France between 2012 and 2017. Methods: AEs related to recreational cannabis use, alone or in combination with alcohol and/or tobacco reported to the French Addictovigila[...]

Plus d'info

Ajouter à la sélection

Lien externe

Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse?

P. VANDERKAM ; S. GAGEY ; P. INGRAND ; M. C. PERAULT-POCHAT ; Y. BRABANT ; C. BLANCHARD ; B. TUDREJ ; N. MESSAADI ; P. BINDER | 2018
Dans Drug and Alcohol Dependence (Vol.188, July 2018) Article : Périodique

Background: In France, buprenorphine is at once the most widely prescribed and the most commonly misused opioid maintenance treatment (OMT). Unlike other medicines, it is seldom prescribed as a generic drug. Several studies have underlined the i[...]

Plus d'info

Ajouter à la sélection

Augmentation des complications sanitaires graves lors de l'usage non-médical du protoxyde d'azote en France

J. MICALLEF ; M. MALLARET ; M. LAPEYRE-MESTRE ; A. DAVELUY ; C. VICTORRI-VIGNEAU ; H. PEYRIERE ; D. DEBRUYNE ; S. DEHEUL ; R. BORDET ; C. CHEVALLIER ; M. C. PERAULT-POCHAT ; R. LE BOISSELIER ; F. LIBERT ; L. CHAOUACHI ; P. GILLET ; Association française des centres d'addictovigilance | 2021
Dans Therapies (Vol.76, n°1, Janvier-Février 2021) Article : Périodique

L'Association française des centres d'addictovigilance alerte sur l'augmentation de l'usage non-médical du protoxyde d'azote en France et sur l'augmentation des complications sanitaires graves, notamment des atteintes neurologiques sévères surve[...]

Plus d'info

Ajouter à la sélection

Consumption of hallucinogenic plants and mushrooms by university students in France: A pilot study [Letter to the editor]

S. PAIN ; A. BATISSE ; I. INGRAND ; B. FAUCONNEAU ; M. C. PERAULT-POCHAT | 2018
Dans Presse Médicale (La) (Vol.47, n°11-12, Novembre-Décembre 2018) Article : Périodique

Observations conducted in France among users of psychoactive substances show that the consumption of hallucinogenic plants and mushrooms is growing. In 2014, 4.8% (3.2% in 2010) of persons aged 18-64 years-old have already used hallucinogenic mu[...]

Plus d'info

Ajouter à la sélection

Dangerous intoxication after oral ingestion of poppers (alkyl nitrites): Two case reports

S. PAIN ; F. CHAVANT ; B. FAUCONNEAU ; J. GUENEZAN ; N. MARJANOVIC ; J. Y. LARDEUR ; B. BRUNET ; M. C. PERAULT-POCHAT | 2017
Dans Therapies (Vol.72, n°3, Juin 2017) Article : Périodique

"Poppers" (alkyl nitrites) were made famous in the 1960s as a party drug and are still used today. They are highly volatile, sweet-smelling liquids commonly administered by inhalation. However, sometimes, they can be consumed by oral ingestion r[...]

Plus d'info

Ajouter à la sélection

Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network

P. GANDOLFO ; T. SOEIRO ; . JOUVE ; B. REVOL ; A. DAVELUY ; C. BERTIN ; C. EIDEN ; V. GIBAJA ; L. CHAOUACHI ; M. C. PERAULT-POCHAT ; C. CHEVALLIER ; A. AQUIZERATE ; R. LE BOISSELIER ; L. CARTON ; M. LAPEYRE-MESTRE ; E. FRAUGER ; C. LACROIX ; J. MICALLEF | 2024
Dans Fundamental and Clinical Pharmacology (Vol.38, n°5, October 2024) Article : Périodique

BACKGROUND: Due to its psychoactive effects, ketamine has become a drug used for non-medical purpose. OBJECTIVES: To assess the latest trends in ketamine use among people with substance use disorder and to characterize its clinical complication[...]

Plus d'info

Ajouter à la sélection

Lien externe

Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment

P. BINDER ; N. MESSAADI ; M. C. PERAULT-POCHAT ; S. GAGEY ; Y. BRABANT ; P. INGRAND | 2016
Dans Journal of Addictive Diseases (Vol.35, n°2, 2016) Article : Périodique

As a form of opioid maintenance treatment, high-dose buprenorphine is increasingly being used in the United States. On the French market since 1996, it is the most commonly prescribed and frequently employed opioid maintenance treatment. For unk[...]

Plus d'info

Ajouter à la sélection

Warning on increased serious health complications related to non-medical use of nitrous oxide [Letter to the editor]

J. MICALLEF ; M. MALLARET ; M. LAPEYRE-MESTRE ; A. DAVELUY ; C. VICTORRI-VIGNEAU ; H. PEYRIERE ; D. DEBRUYNE ; S. DEHEUL ; R. BORDET ; C. CHEVALLIER ; M. C. PERAULT-POCHAT ; R. LE BOISSELIER ; F. LIBERT ; L. CHAOUACHI ; P. GILLET ; French Association of Addictovigilance Centres | 2021
Dans Therapies (Vol.76, n°5, Septembre-Octobre 2021) Article : Périodique

Plus d'info

Ajouter à la sélection

Lien externe